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ABSTRACT. A set of transaminases has been investigated for the biocatalytic amination of 1-(4-
chloropyridin-2-yl)alkan-1-ones. The influence of the chain length of the n-1-alkanone at the C-2 
position of the pyridine has been studied in the reaction with different (R)- and (S)-selective 
transaminases. Thus, enantiopure amines were isolated with high purity starting from a wide 
selection of prochiral ketones. On the one hand excellent yields (97->99% conversion, up to 93% 
isolated yield) and stereoselectivity values (>99% ee for both amine enantiomers) were found for 
n-1-alkanone linear short chain substituents such as ethanone or propanone. On the other hand, 
more hindered substrates were accepted only when using evolved enzymes such as an evolved 
variant of (R)-Arthrobacter (ArRmut11-TA). An initial common structural feature was the 
presence of a chlorine atom on the C-4 position of the pyridine core, which was found to increase 
the reactivity of the starting ketone, giving extra versatility for the introduction of other chemical 
functionalities towards more complex and applicable organic molecules. In order to gain a 
deeper understanding about the substrate specificity of different transaminases, additional 
structural features were considered by variation of the acetyl group position on the pyridine ring 
and the use of related acetophenone derivatives. 
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INTRODUCTION 
The asymmetric synthesis of amines attracts significant attention due to their multiple immediate 
applications and versatility as building blocks in the preparation of bioactive molecules.1 In 
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addition, amines have been widely employed as chiral auxiliaries, asymmetric catalysts and 
chiral resolving agents.2 
Enzymes offer highly sustainable and efficient synthetic alternatives to current existing chemical 
methods,3 providing access to enantiopure amines and derivatives with excellent selectivity.4 
Traditionally, hydrolases have been the biocatalysts of choice for the preparation of optically 
active amines through classical or dynamic kinetic resolutions of the corresponding racemates,5 
but the development of other classes of enzymes such as amine oxidases,6 transaminases,7 
berberine bridge enzymes,8 amine dehydrogenases9 and more recently imine reductases10 
presents biotransformations as versatile tools for the development of highly efficient asymmetric 
transformations to prepare these compounds. 
Transaminases (TAs), also known as aminotransferases (EC 2.6.1.X) or amine transaminases, are 
pyridoxal 5’-phosphate (PLP) dependent enzymes11 that catalyze the kinetic resolution of 
racemic amines and, conversely, asymmetric synthesis of amines from the corresponding 
prochiral ketones.7,12 The latter reaction is preferred over the first as it culminates in a 100% 
theoretical maximum yield. In this sense and taking into account thermodynamic considerations, 
the main limitation of an unfavorable equilibrium shift towards the formation of the amine has 
been broadly studied and overcome by diverse strategies.13 
The pyridine core constitutes an interesting nitrogen-based scaffold, both from a biological and 
synthetic point of view.14 It can participate in chemical transformations either via the nitrogen or 
via the aromatic ring, which makes pyridines attractive compounds for many different 
applications.15 Particularly, the presence of a chlorine atom on the aromatic ring opens up a 
variety of synthetic possibilities for increasing molecular complexity, allowing for instance the 
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preparation of enantiopure 4-(N,N-dimethylamino)-2-(1-hydroxyalkyl)pyridines using lipases16 
or alcohol dehydrogenases,17 compounds that offer interesting applications in asymmetric 
organocatalysis as ligands or chiral catalysts.17 
Herein, we describe the enzymatic transamination of 1-(4-chloropyridin-2-yl)alkan-1-ones 
bearing different size alkyl chains on the C-2 position of the aromatic ring (1a-d, Figure 1 top). 
A range of transaminases overexpressed in E. coli was investigated to establish the optimal 
reaction conditions and study the influence of the substitution pattern on the reactivity of the 
prochiral ketones. Furthermore, additional structural parameters such as the type of aromatic 
ring, the presence of chlorine atoms or the position of the ketone functionality on the aromatic 
ring will be considered (structures 1e-i, Figure 1 bottom), in order to provide an insight in the 
interaction between selected transaminases and aromatic substrates with different structural 
cores. Correlations between conversion of the enzymatic transamination processes and the 
infrared carbonyl stretch of the starting ketones will be done, discussing the best structural motifs 
to allow the displacement of the equilibrium towards the amine formation. 
Figure 1. Chemical structure of 1-(4-chloropyridin-2-yl)alkan-1-ones (top) and structural 
modifications considered for the study of transaminase reactivity (bottom). 
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RESULTS AND DISCUSSION 
Prochiral ketones 1a-d were chemically synthesized starting from commercially available 4-
chloropyridine N-oxide in a two-step sequence previously developed in our research group.16a 
The biocatalytic transamination of ketones 1a-d was initially performed at a 50 mM substrate 
concentration using a set of TAs overexpressed in E. coli (Table 1): the (S)-selective TAs from 
Vibrio fluvialis (Vf)18  and Chromobacterium violaceum (Cv),19 or the (R)-selective TAs from 
(R)-Arthrobacter species (ArR)20 and Aspergillus terreus (At).21 L- or D-alanine (L/D-Ala), 
respectively, were initially used as amine source depending on the enzyme’s selectivity, and the 
equilibrium was shifted towards amine formation by removing the pyruvate to L-alanine with 
alanine dehydrogenase (AlaDH) at the expense of ammonia and formate generating only CO2 
and H2O as byproducts.
22 
As shown in Table 1, quantitative conversions and excellent stereoselectivities were observed for 
the methyl ketone 1a with all tested TAs (entries 1-4). Similarly, access to both enantiomers of 
amine 2b was accomplished by selecting the appropriate TA (entries 5-8). Thus, the enantiopure 
amine (S)-2b was obtained with quantitative conversion (entries 5 and 6) and the complementary 
(R)-antipode with very high conversions (up to 97%, entries 7 and 8). 
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Table 1. Enzyme-catalyzed asymmetric transamination of ketones 1a-d.a 
 
Entry R TA c (%)b ee (%)c 
1 Me (1a) Vf >99 >99 (S) 
2 Me (1a) Cv >99 >99 (S) 
3 Me (1a) ArR >99 >99 (R) 
4 Me (1a) At >99 >99 (R) 
5 Et (1b) Vf >99 >99 (S) 
6 Et (1b) Cv >99 >99 (S) 
7 Et (1b) ArR 95 >99 (R) 
8 Et (1b) At 97 >99 (R) 
9 nPr (1c) Vf 72 >99 (S) 
10 nPr (1c) Cv 14 >99 (S) 
11 nPr (1c) ArR 3 n.m. 
12 nPr (1c) At <1 n.m. 
13 nBu (1d) Vf 15 81 (S) 
14 nBu (1d) Cv 19 <1 
15 nBu (1d) ArR <1 n.m. 
16 nBu (1d) At <1 n.m. 
a Reaction conditions: phosphate buffer (100 mM, pH 7), ketone 1a-d (50 mM), lyophilized cells 
E. coli/TA (20 mg), PLP (1 mM), NAD+ (1 mM), L- or D-alanine (250 mM), AlaDH (10 µL, 11 
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U), formate dehydrogenase (FDH, 2.6 mg, 11 U), ammonium formate (150 mM), 24 h at 30 ºC 
and 700 rpm. 
b Conversion values were determined by GC analysis after isolation of products by extraction 
from basified media (See experimental section). 
c Enantiomeric excess values were measured by GC or HPLC (See Supporting Information) on a 
chiral phase. n.m.: not measured. The stereochemistry of the products, which appear in brackets, 
was confirmed by comparing the corresponding optical rotations with the values reported in 
literature (See experimental section). 
The exquisite preliminary results encouraged us to carry out representative examples on 
preparative scale (50 mg of substrate). Consequently, transamination reactions of methyl ketone 
1a with Cv-TA, allowed the isolation of (S)-2a (ee >99%) in 82% isolated yield. The synthetic 
potential of the Vf-TA was also demonstrated obtaining the same enantiopure amine in 93% 
isolated yield (see Experimental Section). Similarly, Vf-TA led to quantitative transformation 
and 93% isolated yield of (S)-2b after a simple extraction protocol. The isolated amines were 
analyzed by GC and NMR techniques, 2a and 2b being obtained with very high purity without 
no additional purification. 
A dramatic decrease of conversion was observed when bulkier ketones were considered 
containing longer alkyl rests (1c and 1d, propyl and butyl, respectively), which is in agreement 
with previous TA-catalyzed biotransamination examples with structurally similar acetophenone 
derivatives.23 Nevertheless, amine (S)-2c was still obtained with good conversion and in 
enantiopure form when Vf- TA was used (entry 9), while low conversions were attained for the 
(S)-selective Cv-TA or the (R)-selective enzymes (entries 10-12). Other TAs (Arthrobacter 
citreus, Bacillus megaterium, Paracoccus denitrificans, Pseudomonas fluorescens or 
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Hyphomonas neptunium) proved to be not suitable. Low or no detectable conversion was 
obtained for the pentanone 1d in all cases (entries 13-16). 
Since none of the enzymes tested provided an efficient access to the more hindered amines, an 
evolved variant of (R)-Arthrobacter (ArRmut11-TA) was explored, also displaying (R)-
selectivity as the wild-type enzyme. This enzyme has been previously successfully applied in the 
transamination of sterically demanding substrates,24 and presents additional advantages as its 
high thermal stability and tolerance to 2-propylamine as amine source. Thus, the reaction was 
run at elevated temperature (45 ºC) circumventing a recycling system by adding an excess of the 
amine donor. The results are summarized in Table 2. 
Table 2. Asymmetric transamination of ketones 1a-d using the ArRmut11-TA.a 
 
Entry R TA preparation 
c 
(%)b 
ee 
(%)c 
1 nBu (1d) crude 64 >99 
2 nBu (1d) semipurified 87 >99 
3 nPr (1c) crude 66 >99 
4 nPr (1c) semipurified 96 >99 
5 Et (1b) semipurified 97 >99 
6 Me (1a) semipurified 98 99 
a Reaction conditions: phosphate buffer (100 mM, pH 7), ketone 1a-d (50 mM), ArRmut11-TA 
(20 mg of crude enzyme or 500 µL of semipurified version), PLP (0.5 mM), 2-propylamine (1 
M), 24 h at 45 ºC and 700 rpm. 
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b Conversion values were determined by GC analysis after isolation of products by extraction 
from basified media (See experimental section). 
c Enantiomeric excess values were measured by GC or HPLC (See Supporting Information) on a 
chiral phase. 
Good conversions and excellent enantiomeric excesses were achieved with the ArRmut11-TA 
crude preparation for the formation of (R)-amines 2d and 2c (entries 1 and 3). Next, a 
semipurified preparation of the enzyme was tested aiming for an improvement of the conversion 
values. Indeed, very high conversions were detected (84-98%) without affecting the selectivity of 
the reaction. As a proof of concept, scale up of the process was performed using 50 mg of 
substrate 1c, recovering the enantiopure amine (R)-2c in 68% isolated yield after an extraction 
step. The biocatalytic system was also successfully used for the preparation of amines bearing 
short alkyl chains (2a-b, R=Me, Et) reaching completion within 24 h (entries 6 and 5, 
respectively). 
In order to get a deeper insight about the structure-activity relationship for TAs, additional 
enzymatic studies were performed by considering structural parameters such as: (i) chain length 
of the alkyl group, (ii) presence of nitrogen and chlorine atoms in/on the aromatic ring; (iii) the 
position of substitution of the acyl group on the pyridine ring. 
The transamination of ketones 1a-d was followed over time catalyzed by the (S)-selective Vf-TA 
(Figure 2), which displayed a good activity even for the butanone 1c (72% conversion, entry 9 in 
Table 1). The ethanone 1a (R=Me) was converted very quickly under the reaction conditions 
employed reaching 74% conversion in 1 hour, and almost complete consumption of the ketone 
after 7 hours. On the other hand, propanone 1b (R=Et) was transformed more slowly. Reaction 
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progress was similar for substrates 1b and 1c at 1 and 3 hours (5 vs. 3% and 14 vs. 12% 
conversion, respectively), the difference between these two ketones became more significant 
after 5 hours (34 vs. 18% conversion) and 7 hours (44 vs. 26% conversion). In line with the 
conversions achieved before (entry 13 in Table 1), the pentanone 1d (R=Bu) only reached 4% of 
conversion at 7 hours, which clearly illustrates the decrease of reactivity for substrates bearing 
medium-large aliphatic chains. 
 
  
Figure 2. Graphical representation of Vf-TA reactivity as function of the chain size of ketones 
1a-d after 1, 3, 5 and 7 hours. 
Following our aim to establish a structure-activity relationship for TAs, we focused next on other 
structural aspects related to the aromatic ring, including the presence of heteroatoms (nitrogen 
and chlorine) and the position of the acetyl group on the pyridine ring. Therefore, ethanone 1a 
was chosen as model substrate and methyl ketones 1e-i were included in this study (Figure 1). 
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Amination experiments were carried out employing transaminases of complementary 
stereopreference, under previously optimized reaction conditions (temperature, substrate 
concentrations, amine donors, recycling systems, reaction time, pH and type of buffer) for an 
accurate comparison between substrates (Scheme 1). 
 
Scheme 1. Enzymatic transamination of 1a and 1e-i using alanine or 2-propylamine as amino 
donor. 
The amination of 1a,e-i was performed using various TAs (10 mg E. coli/TA, 1 h) at 30 ºC for 
Vf, Cv, ArR, while 45 ºC was selected for the more thermostable ArRmut11-TA used as 
semipurified preparation (500 μL, 8 U, Figure 3). From the results obtained some general facts 
concerning their reactivity can be concluded. A decrease in conversion values was detected when 
comparing the model substrate 1-(4-chloropyridin-2-yl)ethan-1-one (1a, conversion up to 87%) 
with 2-acetylpyridine (1f, conversion up to 50%), which lacks the chlorine atom on the C-4 
position. This drop in the conversion became more significant when investigating aromatic 
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derivatives such as 3’-chloroacetophenone (1e, conversion up to 17%) and acetophenone (1g), 
which reached the highest conversion (21%) using the (R)-selective ArR-TA. A similar tendency 
was observed with 3-acetylpyridine (1h, conversion up to 19%), while no reaction was found 
with semipurified ArRmut11-TA. Finally, the amination of 4-acetylpyridine (1i) was studied, 
finding a similar trend with respect to 2-acetylpyridine (1f), reaching the best conversion (42% 
and 57%) with the Cv- and ArR-TAs, respectively. In any case, there are major differences 
compared to 1-(4-chloropyridin-2-yl)ethan-1-one (1a) and in fact conversions for 4-
acetylpyridine (1i) are just comparable to those for 2-acetylpyridine (1f). 
 
 
Figure 3. Reactivity comparison for the amination of the methyl ketones 1a,e-i with (a) Cv, (b) 
Vf and (c) ArR-TAs (30 ºC, 1 h), and (d) ArRmut11-TA (45 ºC, 1 h). 
Interestingly, an analysis of the spectroscopical data revealed a positive correlation between 
conversions and vibrational frequencies of the carbonyl band in the infrared spectra for ketones 
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1a,e-i, and therefore with the C=O bond length.25 The conversions achieved with Cv-TA for 
various substrates presented in Figure 4 shows this correlation with the electronic effect of the 
chlorine atom and the pyridine nitrogen, the last being the predominant one. The pyridine 
derivatives 1a, 1f and 1i bearing the acetyl group at C-2 or C-4 positions, in which the electron 
withdrawing effect of the nitrogen is stronger, displayed frequencies higher than 1690 cm-1, 
those compounds leading to higher conversion values. Among them, the pyridine 1a is the more 
reactive one as it has the additional electron withdrawing effect of the chlorine. On the contrary, 
the larger C=O bonds fit to the acetophenone derivatives 1g and 1e, and to the pyridine 1h, in 
which the conversion of the reaction reached a maximum 10% after 1 hour. The acetophenone 1e 
with a chlorine atom and the pyridine 1h displayed a slight higher reactivity than acetophenone 
(1g), which does not present the electron withdrawing effects of 1e and 1h. 
 
Figure 4. Graphical representation of vibrational frequencies of the carbonyl IR band (bars) 
towards conversion values (line) in the enzyme-catalyzed transamination of 1a and 1e-i using 
Cv-TA (700 rpm, 30 ºC and 1 hour). 
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Finally, the high conversions observed for 1a within 1 hour using semipurified ArRmut11-TA 
(85% conversion, Figure 3d) might indicate a higher thermodynamic stability of the product 
amine 2a, which may facilitate a shift of the equilibrium towards its formation. In this case, less 
amount of the amine donor (2-propylamine) would be required for a practical biotransformation. 
Accordingly, the concentration of 2-propylamine was reduced from 1 M to 100 mM (Table 3). In 
addition, the same experiment was made employing 3’-chloroacetophenone (1e). 
Table 3. Asymmetric enzyme-catalyzed transamination of 1a and 1e using semipurified 
ArRmut11-TA.a 
 
Entry X 
[2-propylamine] 
(M) 
t 
(h) 
c 
(%)b 
1 N (1a) 1 1 85 
2 N (1a) 1 24 98 
3 N (1a) 0.1 24 76 
4 CH (1e) 1 1 39 
5 CH (1e) 1 24 53 
6 CH (1e) 0.1 24 24 
a Reaction conditions: phosphate buffer (100 mM, pH 7), ketone 1a and 1e (50 mM), ArRmut11-
TA (500 µL), PLP (0.5 mM), 2-propylamine (0.1-1 M), 1-24 h at 45 ºC and 700 rpm. 
b Conversion values were determined by GC analysis after isolation of products by extraction 
from basified media (See experimental section). 
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Differences between substrate 1a and 1e are for instance the higher conversion for 1a (85% vs. 
39%) after 1 hour at 1 M of 2-propylamine (entries 1 and 4), something already discussed. 
Furthermore, at 100 mM 2-propylamine concentration, ketone 1e reached 24% conversion after 
24 h (entry 6), while the reaction with 1a achieved 76% (entry 3). The values obtained for 1e are 
in agreement with the fact that the deamination reaction is favored for acetophenone derivatives 
compared to the reverse amination reaction.26 On the other hand, the excellent results obtained 
for the amination of 1a even with low excesses of amine donor are consistent with 
thermodynamic preference for the formation of amine (R)-2a. This inclination was analyzed 
through different perspectives. The first attempt to explain it focuses on an intramolecular 
hydrogen bond between the amino group and the pyridine nitrogen which would provide an 
additional stabilization to the amine and therefore drive the reaction to the amination direction.27 
Computational studies28 on the model substrate 2a confirmed the presence of the hydrogen bond 
(Figure S4, for further details see the Supporting Information). 
Alternatively, energy calculations supported the thermodynamic stabilization by the difference 
observed in the ΔG of the reaction for the amination of both ketones 1a and 1e, the pyridine 
transformation being 4.3 kJ/mol more favorable (see Table S1 and Figure S3). 
CONCLUSIONS 
The asymmetric synthesis of 1-(4-chloropyridin-2-yl)alkan-1-amines has been performed 
through transaminase-catalyzed reactions starting from their corresponding prochiral ketones. 
Hence, ethan- and propanone derivatives were successfully transformed with a variety of (R)- 
and (S)-selective transaminases. After finding adequate reaction conditions, both amine 
antipodes have been obtained with excellent conversion values and high to excellent isolated 
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yields in preparative biotransformations, recovering the desired amines with high purity after a 
simple extraction protocol. To achieve full stereoselectivity and high conversion for the most 
hindered pyridine substrates, the use of an evolved variant from (R)-Arthrobacter species was 
required. The 1-(4-chloropyridine-2-yl)ethan-1-one 1a was transformed very efficiently even at 
reduced concentration of amine donor most likely due to thermodynamic reasons as a result of 
the formation of an internal hydrogen bond. Different structural parameters including pyridine 
and acetophenone derivatives, some bearing chlorine atoms at the aromatic ring, and with the 
alkanone rest at variable positions in the aromatic ring were examined, which enabled to identify 
ideal structural motives for the substrate to be converted by the enzymes investigated. 
EXPERIMENTAL SECTION 
1-(4-Chloropyridine-2-yl)alkan-1-ones 1a-d and racemic amines 2a-d were prepared according 
to previously reported procedures from 4-chloropyridine N-oxide.16 Chemical reagents and 
solvents were used as received from commercial sources. 
TLC analyses were carried out with precoated aluminium sheets (TLC silica gel 60 F254, 
Merck) with detection by UV or staining with potassium permanganate or ninhydrin. Preparative 
chromatographic separations were performed by flash chromatography on Merck silica gel (230-
400 mesh). Optical rotation was measured at 20 °C with a Perkin-Elmer 241 polarimeter at the 
sodium D-line. 1H and 13C NMR spectra were recorded at 20 °C with a Bruker 300 MHz unit; 
chemical shifts are given in ppm relative to the resonance of the solvent. Analytical data and 
retention times for the measurement of conversion and enantiomeric excess values are given in 
the Supporting Information section. The purity of the resulting optically active amines obtained 
through transaminase-catalyzed processes was determined by GC and NMR analyses. 
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Formate dehydrogenase was purchased from Evocatal GmbH (lyophilized powder 4.1 U/mg) and 
NAD+ free acid were purchased from Codexis Inc. Lyophilized E. coli cells containing 
overexpressed transaminases were prepared as previously reported.20a,29 Lyophilized cells applied 
as catalyst displayed the following activities (determined for the deamination of α-
methylbenzylamine with pyruvate): ArR: 2.2 U/mg, ArRmut11: 0.3 U/mg, At: 0.5 U/mg, Vf: 1.3 
U/mg, Cv: 2.1 U/mg, purified L-alanine dehydrogenase: 1.1 U/µL. Small scale reactions were 
shaken in 2 mL thermo shaker Eppendorf® Comfort. Preparative scale reactions were performed 
in an Infors Unitron shaker. 
Heat purification protocol for ArRmut11 
Lyophilized E. coli cells containing overexpressed enzyme (2 g) were suspended in a 100 mM 
phosphate buffer pH 7 (20 mL) and the suspension was sonicated with the following protocol: 1 
s pulse; 4 s pause; 2.5 min; 40% amplitude. The mixture was centrifuged for 20 min at 45000 g 
and 4 ºC and the supernatant was treated for 30 min at 50 ºC. After this time the suspension was 
centrifuged again for 20 min at 45000 g and 4 ºC and the supernatant containing the active 
enzyme was stored at -18 ºC. Protein concentration: 26.7 mg/mL according to Bradford’s assay. 
Activity (determined for the deamination of α-methylbenzylamine with pyruvate): 16 U/mL. 
Typical procedure for asymmetric transamination of ketones 1a-d employing alanine 
dehydrogenase as regeneration system 
To a suspension of ketones 1a-d (0.05 mmol, 50 mM) in a 100 mM phosphate buffer pH 7 (440 
µL) were successively added ammonium formate (100 µL of 1.5 M solution in a 100 mM 
phosphate buffer pH 7; final concentration 150 mM), alanine (250 µL of 1 M solution in 
phosphate buffer 100 mM pH 7; final concentration 250 mM), NAD+ (100 µL of 10 mM solution 
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in a 100 mM phosphate buffer pH 7; final concentration 1 mM), PLP (100 µL of 10 mM solution 
in a 100 mM phosphate buffer pH 7; final concentration 1 mM), lyophilized cells of E. coli 
containing overexpressed transaminases (20 mg), formate dehydrogenase (FDH, 2.6 mg, 11 U) 
and alanine dehydrogenase (AlaDH, 10 µL, 11 U). D- or L- alanine were used as amine donor 
depending on the (R) or (S)-transaminase selectivity, respectively.  
The resulting mixture was shaken at 30 °C and 700 rpm for 24 h. After this time the reaction was 
quenched by adding aqueous NaOH 4 M (400 µL), extracted with ethyl acetate (3 x 500 µL), and 
organic phases were combined and dried with Na2SO4. Reaction crude was analyzed through GC 
to determine conversion values and, after an in situ derivatization, enantiomeric excess. 
Typical experimental procedure for asymmetric transamination of ketones 3a-d catalyzed 
by semipurified ArRmut11-TA 
Ketones 1a-d (0.05 mmol, 50 mM) were suspended in a 100 mM phosphate buffer pH 7 (500 
µL) containing PLP (1 mM; final concentration 0.5 mM) and isopropylamine (2 M; final 
concentration 1 M). Then, semipurified ArRmut11 (500 µL) was added and the mixture was 
shaken at 45 °C and 700 rpm for 24 h. The reaction was quenched by adding aqueous NaOH 4 M 
(400 µL), extracted with ethyl acetate (3 x 500 µL), and organic phases were combined and dried 
with Na2SO4. Reaction crude was analyzed through GC to determine conversion values and, 
after an in situ derivatization, enantiomeric excess. 
General procedure for preparative reductive amination of 1a and 1b employing alanine 
dehydrogenase as regeneration system 
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To a suspension of ketones 1a or 1b (0.32 mmol, 50 mM) in a 100 mM phosphate buffer pH 7 
(2.8 mL) were successively added ammonium formate (643 µL of 1.5 M solution in a 100 mM 
phosphate buffer pH 7; final concentration 150 mM), L-alanine (1.6 mL of 1 M solution in a 100 
mM phosphate buffer pH 7; final concentration 250 mM), NAD+ (643 µL of 10 mM solution in a 
100 mM phosphate buffer pH 7; final concentration 1 mM), PLP (643 µL of 10 mM solution in a 
100 mM phosphate buffer pH 7; final concentration 1 mM), lyophilized cells of E. coli 
containing overexpressed transaminases (32 mg for 1a, 96 mg for 1b), formate dehydrogenase 
(16.4 mg, 69 U) and AlaDH (63 µL, 69 U). The resulting mixture was shaken at 30 °C and 120 
rpm for 24 h. The reaction was quenched by adding aqueous NaOH 4 M until pH ≈ 10 and 
extracted with ethyl acetate (3 x 10 mL). The organic phases were combined, dried with Na2SO4 
and the solvent was removed under reduced pressure. Enantiopure amines (S)-2a and (S)-2b 
were isolated as colorless liquids in 82-93% yield. For (S)-2a in >99% ee: D20 = -23.4 (c 0.5, 
CHCl3); lit. D20 = -20.4 (c 0.5, CHCl3).16b For (S)-2b in >99% ee: D20 = -5.8 (c 0.6, CHCl3); 
lit. D20 = -5.1 (c 0.6, CHCl3).16b 
Preparative reductive amination of 1c catalyzed by semipurified ArRmut11-TA 
In a Falcon tube, ketone 1c (50 mg, 0.27 mmol, 50 mM) was suspended in a 100 mM phosphate 
buffer pH 7 (2.7 mL) containing PLP (1 mM; final concentration 0.5 mM) and isopropylamine (2 
M; final concentration 1 M). Then, semipurified ArRmut11-TA (2.7 mL) was added and the 
mixture was shaken at 45 °C and 120 rpm for 24 h. The reaction was quenched by adding 
aqueous NaOH 4 M until pH ≈ 10 and extracted with ethyl acetate (3 x 10 mL). The organic 
phases were combined, dried with Na2SO4 and the solvent was removed under reduced pressure. 
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Enantiopure amine (R)-2c was isolated as colorless liquid in 68% yield. For (R)-2c in >99% ee: 
D20 = +10.8 (c 0.5, CHCl3); lit. D20 = -9.1 (c 0.5, CHCl3) for (S)-2c in 98% ee].16b 
ASSOCIATED CONTENT 
Supporting Information. 
Information about the transaminases employed in this study, details of the computational 
calculations, the chemical synthesis of the starting and reference materials including the NMR 
data of the products, the specific data of the conversions depicted in Figures 2 and 3, the 
analytics including the chromatograms, as well as the NMR spectra for described organic 
compounds. This material is available free of charge via the Internet at http://pubs.acs.org 
AUTHOR INFORMATION 
Corresponding Author 
* E-mail: vicgotfer@uniovi.es 
* E-mail: wolfgang.kroutil@uni-graz.at 
* E-mail: bbusto@ucm.es 
Author Contributions 
The manuscript was written through contributions of all authors. All authors have given approval 
to the final version of the manuscript. 
ACKNOWLEDGMENT 
Financial support of this work by the Spanish Ministerio de Economía y Competitividad (CTQ-
2013-44153-P project) and the Asturian Regional Government (FC-15-GRUPIN14-002) are 
gratefully acknowledged. M.L.-I. and D.G.-M. thank FICYT for a predoctoral fellowship. E. B. 
 21 
thanks the European Union for a Marie Curie IEF grant (Project IEF-2011-BIOCASCADE). We 
thank R. Soria-Martínez for the assistance in computational studies. 
ABBREVIATIONS 
TA, transaminase; E. coli, Escherichia coli; Vf, Vibrio fluvialis; Cv, Chromobacterium 
violaceum; ArR, Arthorbacter species; At, Aspergillus terreus; AlaDH, alanine dehydrogenase; 
FDH, formate dehydrogenase; TLC, thin layer chromatography. 
REFERENCES  
(1) (a) Breuer, M.; Ditrich, K.; Habicher, T.; Hauer, B.; Keßeler, M.; Stürmer, R.; Zelinski, T. 
Angew. Chem. Int. Ed. 2004, 43, 788-824; (b) Kasprzyk-Hordern, B. Chem. Soc. Rev. 2010, 39, 
4466-4503; (c) Nugent, T. C. Chiral Amine Synthesis: Methods, Developments and Applications, 
Wiley-VCH, Weinheim, 2010. 
(2) For recent reviews: (a) Pan, X.; Liu, Z. Tetrahedron 2014, 70, 4602-4610; (b) Yu, J.-S.; Liao, 
F.-M.; Gao, W.-M.; Liao, K.; Zuo, R.-L.; Zhou, J. Angew. Chem. Int. Ed. 2015, 54, 1-6; (c) 
Zhang, Z.; Wu, W.; Liao, J.; Li, J.; Jiang, H. Chem. Eur. J. 2015, 21, 6708-6712. 
(3) (a) Faber, K. Biotransformations in Organic Chemistry, 6th Ed., Springer, New York, 2011; 
(b) Drauz, K.; Gröger, H.; May, O.; Enzyme Catalysis in Organic Synthesis, 3rd Ed., Wiley-VCH, 
Weinheim, 2012; (c) Faber, K.; Fessner, W.-D.; Turner, N. J. Science of Synthesis, Biocatalysis 
in Organic Synthesis, Georg Thieme Verlag, Stuttgart, 2015; (d) Nestl, B. M.; Hammer, S. C.; 
Nebel, B. A.; Hauer, B. Angew. Chem. Int. Ed. 2014, 53, 3070-3095. 
(4) (a) Höhne, M.; Bornscheuer, U. T.; ChemCatChem 2009, 1, 42-51; (b) Kroutil, W.; 
Fischereder, E.-M.; Fuchs, C. S.; Lechner, H.; Mutti, F. G.; Pressnitz, D.; Rajagopalan, A.; 
Sattler, J. H.; Simon, R. C.; Siirola, E. Org. Process Res. Dev. 2013, 17, 751-759; (c) Ghislieri, 
 22 
D.; Turner, N. J. Top. Catal. 2014, 57, 284-300; (d) Kohls, H.; Steffen-Munsberg, F.; Höhne, M. 
Curr. Opin. Chem. Biol. 2014, 19, 180-192. 
(5) (a) van Rantwijk, F.; Sheldon, R. A. Tetrahedron 2004, 60, 501-519; (b) Gotor-Fernández, 
V.; Gotor, Curr. V. Org. Chem. 2006, 10, 1125-1143; (c) Busto, E.; Gotor-Fernández, V.; Gotor, 
V. Chem. Rev. 2011, 111, 3998-4035; (d) Verho, O.; Bäckvall, J.-E. J. Am. Chem. Soc. 2015, 
137, 3996-4009. 
(6) For selected examples: (a) Köhler, V.; Wilson, Y. M.; Dürrenberger, M.; Ghislieri, D.; 
Churakova, E.; Quinto, T.; Knörr, L.; Haüssinger, D.; Hollmann, F.; Turner, N. J.; Ward, T. R. 
Nat. Chem. 2013, 5, 93-99; (b) Ghislieri, D.; Green, A. P.; Pontini, M.; Willies, S. C.; Rowles, I.; 
Frank A.; Grogan, G.; Turner, N. J. J. Am. Chem. Soc. 2013, 135, 10863-10869; (c) Li, G.; Ren, 
J.; Yao, P.; Duan, Y.; Zhang, H.; Wu, Q.; Feng, J.; Lau, P. C. K.; Zhu, D. ACS Catal. 2014, 4, 
903-908; (d) Heath, R. S.; Pontini, M.; Bechi, B.; Turner, N. J. ChemCatChem 2014, 6, 996-
1002. 
(7) (a) Mathew, S.; Yun, H. ACS Catal. 2012, 2, 993-1001; (b) Simon, R. C.; Richter, N.; Busto, 
E.; Kroutil, W. ACS Catal. 2014, 4, 129-143; (c) Fuchs, M.; Farnberger, J. E.; Kroutil, W. Eur. J. 
Org. Chem. 2015, 6965-6982. 
(8) For selected examples: (a) Schrittwieser, J. H.; Resch, V.; Sattler, J. H.; Lienhard, W. D.; 
Durchschein, K.; Winkler, A.; Gruber, K.; Macheroux, P.; Kroutil, W. Angew. Chem. Int. Ed. 
2011, 50, 1068-1071; (b) Resch, V.; Schrittwieser, J. H.; Wallner, S.; Macheroux, P.; Kroutil, W. 
Adv. Synth. Catal. 2011, 353, 2377-2383; (c) Resch, V.; Lechner, H.; Schrittwieser, J. H.; 
Wallner, S.; Gruber, K.; Macheroux, P.; Kroutil, W. Chem. Eur. J. 2012, 18, 13173-13179. (d) 
 23 
Gandomkar, S.; Fischereder, E.-M.; Schrittwieser, J. H.; Wallner, S.; Habibi, Z.; Macheroux, P.; 
Kroutil, W. Angew. Chem. Int. Ed. 2015, 54, 15051-15054. 
(9) For selected examples: (a) Abrahamson, M. J.; Vázquez-Figueroa, E.; Woodall, N. B.; 
Moore, J. C.; Bommarius, A. S. Angew. Chem. Int. Ed. 2012, 51, 3969-3972; (b) Abrahamson, 
M. J.; Wong, J. W.; Bommarius, A. S. Adv. Synth. Catal. 2013, 355, 1780-1786.; (c) Mutti, F. 
G.; Knaus, T.; Scrutton, N. S.; Breuer, M.; Turner, N. J. Science 2015, 349, 1525-1529. 
(10) (a) Gamenara, D.; Domínguez de María, P. Org. Biomol. Chem. 2014, 12, 2989-2992; (b) 
Schrittwieser, J. H.; Velikogne, S.; Kroutil, W. Adv. Synth. Catal. 2015, 357, 1655-1685; (c) 
Grogan, G.; Turner, N. J. Chem. Eur. J. 2016, 22, 1900-1907. 
(11) Steffen-Munsberg, F.; Vickers, C.; Kohls, H.; Land, H.; Mallin, H.; Nobili, A.; Skalden, L.; 
van den Bergh, T.; Joosten, H.-J.; Berglund, P.; Höhne, M.; Bornscheuer, U. T. Biotechnol Adv. 
2015, 33, 566-604. 
(12) (a) Malik, M. S.; Park, E.-S.; Shin, J.-S. Appl. Microbiol. Biotechnol. 2012, 94, 1163-1171; 
(b) Koszelewski, D.; Tauber, K.; Faber, K.; Kroutil, W. Trends Biotechnol. 2010, 28, 324-332. 
(13) See for instance: (a) Abu, R.; Woodley, J. ChemCatChem 2015, 7, 3094-3105; (b) Meier, R. 
J.; Gundersen, M. T.; Woodley, J. M.; Schürmann, M. ChemCatChem 2015, 7, 2594-2597; (c) 
Tufvesson, P., Lima-Ramos, J., Jensen, J. S.; Al-Haque, N.; Neto, W.; Woodley, J. M. 
Biotechnol. Bioeng. 2011, 78, 108, 1479-1493. 
(14) Hill, M. D. Chem. Eur. J. 2010, 16, 12052-12062; (b) Scriven, E. F. V.; Murugan, R. J. 
Indian Chem. Soc. 2013, 90, 1829-1839. 
 24 
(15) (a) Rycke, N. D.; Couty, F.; David, O. R. P. Chem. Eur. J. 2011, 17, 12852-12871; (b) 
Rajput, A.; Mukherjee, R. Coord. Chem. Rev. 2013, 257, 350-368; (c) de Ruiter, G.; Lahav, M.; 
van der Boom, M. E. Acc. Chem. Res. 2014, 47, 3407-3416. 
(16) (a) Busto, E.; Gotor-Fernández, V.; Gotor, V. Tetrahedron: Asymmetry 2005, 16, 3427-
3435; (b) Torre, O.; Busto, E.; Gotor-Fernández, V. Gotor, V. Adv. Synth. Catal. 2007, 349, 
1481-1488. 
(17) (a) Busto, E.; Gotor-Fernández, V.; Gotor, V. Tetrahedron: Asymmetry, 2006, 17, 1007-
1016; (b) Busto, E.; Gotor-Fernández, V.; Gotor, V. Adv. Synth. Catal. 2006, 348, 2626-2632. 
(18) Hwang, B.-Y.; Cho, B.-K.; Yun, H.; Koteshwar, K.; Kim, B.-G. J. Mol. Catal. B: Enzym. 
2005, 37, 47-55. 
(19) Kaulman, U.; Smithies, K.; Smith, M. E. B.; Hailes, H. C.; Ward, J. M. Enzyme Microb. 
Technol. 2007, 41, 628-637. 
(20) (a) Mutti, F. G.; Fuchs, C. S.; Pressnitz, D.; Sattler, J. H.; Kroutil, W. Adv. Synth. Catal. 
2011, 353, 3227-3233; (b) Iwasaki, A.; Yamada, Y.; Kizaki, N.; Ikenaka, Y.; Hasegawa, J. Appl. 
Microbiol. Biotechnol. 2006, 69, 499-505; (c) Yamada, Y.; Iwasaki, A.; Kizaki N. (Kaneka 
Corporation), EP 0987332 A1, 2000. 
(21) Busto, E.; Simon, R. C.; Grischek, B.; Gotor-Fernández, V.; Kroutil, W. Adv. Synth. Catal. 
2014, 356, 1937-1942. 
(22) Koszelewski, D.; Lavandera, I.; Clay, D.; Guebitz, G. M.; Rozzell, D.; Kroutil, W. Angew. 
Chem. Int. Ed. 2008, 47, 9337-9340. 
 25 
(23) (a) Nobili, A.; Steffen-Munsberg, F.; Kohls, H.; Trentin, I.; Schulzke, C.; Höhne, M.; 
Bornscheuer, U. T. ChemCatChem 2015, 7, 757-760; (b) Deszcz, D.; Affaticati, P.; Ladkau, N.; 
Gegel, A.; Ward, J. M.; Hailes, H. C.; Dalby, P. A. FEBS J. 2015, 282, 2512-2526. 
(24) Savile, C. K.; Janey, J. M.; Mundorff, E. M.; Moore, J. C.; Tam, S.; Jarvis, W. R.; Colbeck, 
J. C.; Krebber, A.; Fleitz, F. J.; Brands, J.; Devine, P. N.; Huisman, G. W.; Georges, G. J. 
Science 2010, 329, 305-309. 
(25) (a) Takayama, S.; Lee, S. T.; Hung, S.-C.; Wong, C.-H. Chem. Commun. 1999, 127-128; (b) 
Breen, G. F. Tetrahedron: Asymmetry 2004, 15, 1427-1430; (c) Contente, M. L.; Serra, I.; 
Palazzolo, L.; Parravicini, C.; Gianazza, E.; Eberini, I.; Pinto, A.; Guidi, B.; Molinari, F.; 
Romano, D. Org. Biomol. Chem. 2016, 14, 3404-3408. 
(26) Park, E. S.; Malik, M. S.; Dong, J.-Y.; Shin, J. S. ChemCatChem 2013, 5, 1734-1738. 
(27) For a similar effect see: Mutti, F. G.; Kroutil, W. Adv. Synth. Catal. 2012, 354, 3409-3413. 
(28) Soria-Martínez, R.; Mendoza-Merono, R.; García-Granda, S. J. Mol. Struct. 2016, 1105, 
322-331. 
(29) (a) Koszelewski, D.; Goritzer, M.; Clay, D.; Seisser, B.; Kroutil, W. ChemCatChem 2010, 2, 
73-77; (b) Mutti, F. G.; Fuchs, C. S.; Pressnitz, D.; Turrini, N. G.; Sattler, J. H.; Lerchner, A.; 
Skerra, A.; Kroutil, W. Eur. J. Org. Chem. 2012, 1003-1017. 
  
 26 
TABLE OF CONTENT GRAPHIC 
 
